These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9704469)

  • 21. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fetal RhD genotyping from maternal plasma.
    Lo YM
    Ann Med; 1999 Oct; 31(5):308-12. PubMed ID: 10574502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid molecular determination of fetal rhesus E type.
    Geifman-Holtzman O; Bernstein IM; Berry SM; Bianchi DW; Holtzman EJ
    Prenat Diagn; 1996 Jun; 16(6):489-93. PubMed ID: 8809889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prenatal typing of Rh- and Kell- blood group system antigens].
    Faas BH; Maaskant-van Wijk PA; Beuling EA; Overbeeke MA; van der Schoot CE; Christiaens GC
    Ned Tijdschr Geneeskd; 1999 Sep; 143(36):1804-7. PubMed ID: 10526582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fetal blood group determination in first-trimester pregnancy for the management of severe immunization.
    Kanhai HH; Gravenhorst JB; Gemke RJ; Overbeeke MA; Bernini LF; Beverstock GC
    Am J Obstet Gynecol; 1987 Jan; 156(1):120-3. PubMed ID: 3099576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis.
    Manfroi S; Calisesi C; Fagiani P; Gabriele A; Lodi G; Nucci S; Pelliconi S; Righini L; Randi V
    Blood Transfus; 2018 Nov; 16(6):514-524. PubMed ID: 29757138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fetal RHD genotyping in maternal serum during the first trimester of pregnancy.
    Costa JM; Giovangrandi Y; Ernault P; Lohmann L; Nataf V; El Halali N; Gautier E
    Br J Haematol; 2002 Oct; 119(1):255-60. PubMed ID: 12358932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-invasive antenatal diagnosis.
    Gaudoin MR
    Lancet; 1993 Jul; 342(8862):54-5. PubMed ID: 8100327
    [No Abstract]   [Full Text] [Related]  

  • 29. Antenatal tests in the diagnosis and assessment of severity of haemolytic disease (Hd) of the fetus and newborn (hdn).
    Contreras M
    Vox Sang; 1994; 67 Suppl 3():207-10. PubMed ID: 7975494
    [No Abstract]   [Full Text] [Related]  

  • 30. Prenatal determination of fetal blood group status.
    Avent ND; Finning KM; Martin PG; Soothill PW
    Vox Sang; 2000; 78 Suppl 2():155-62. PubMed ID: 10938946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.
    Slootweg YM; Koelewijn JM; van Kamp IL; van der Bom JG; Oepkes D; de Haas M
    BJOG; 2016 May; 123(6):955-63. PubMed ID: 26661943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discordance between fetal RhD typing using molecular methods and neonatal typing with serology.
    Van Den Veyver IB; Yankowitz J; Subramanian SB; Dorman KF; Moise KJ
    Gynecol Obstet Invest; 1999; 48(4):229-31. PubMed ID: 10592422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prenatal genotyping of the RhD locus by polymerase chain reaction in fetus at risk of hemolytic disease].
    Misković B; Stipoljev F; Hadzisejdić I; Grahovac B
    Lijec Vjesn; 2008; 130(1-2):4-6. PubMed ID: 18589635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND
    Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An innovative test for non-invasive Kell genotyping on circulating fetal DNA by means of the allelic discrimination of K1 and K2 antigens.
    Cro' F; Lapucci C; Vicari E; Salsi G; Rizzo N; Farina A
    Am J Reprod Immunol; 2016 Dec; 76(6):499-503. PubMed ID: 27730708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prenatal determination of fetal rhesus factor in amnionic cells using polymerase chain reaction].
    Crombach G; Picard F; Beckmann MW; Niederacher D; Bender HG
    Geburtshilfe Frauenheilkd; 1995 Oct; 55(10):577-9. PubMed ID: 8543131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How do I manage Rh typing in obstetric patients?
    Haspel RL; Westhoff CM
    Transfusion; 2015 Mar; 55(3):470-4. PubMed ID: 25647404
    [No Abstract]   [Full Text] [Related]  

  • 38. Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient.
    Judd WJ; Luban NL; Ness PM; Silberstein LE; Stroup M; Widmann FK
    Transfusion; 1990 Feb; 30(2):175-83. PubMed ID: 2154871
    [No Abstract]   [Full Text] [Related]  

  • 39. ACP Broadsheet No 150. March 1997. Antenatal serological testing and prevention of haemolytic disease of the newborn.
    Duguid JK
    J Clin Pathol; 1997 Mar; 50(3):193-6. PubMed ID: 9155667
    [No Abstract]   [Full Text] [Related]  

  • 40. Prenatal genotyping of the Duffy blood group system by allele-specific polymerase chain reaction.
    Hessner MJ; Pircon RA; Johnson ST; Luhm RA
    Prenat Diagn; 1999 Jan; 19(1):41-5. PubMed ID: 10073905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.